
|Articles|November 15, 2003
Refractec files PMA for presbyopia procedure
Irvine, CA-Refractec Inc. has filed its pre-market approval application with the FDA for a conductive keratoplasty (CK) procedure designed for patients with presbyopia.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
2
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
3
Opuviz aflibercept biosimilar launches in Europe for retinal diseases
4
Study links alcohol consumption to earlier advanced presbyopia in men
5





















